Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
YSB Inc. ( (HK:9885) ) has issued an update.
YSB Inc. announced that its Trustee has purchased 120,000 shares for the Share Incentive Plan at HK$682,992, with a recent total of 560,000 shares acquired at HK$3.19 million. This move reflects the company’s belief that its current share price is undervalued and its confidence in its business prospects, aligning key employee interests with the company’s goals for sustainable growth.
More about YSB Inc.
YSB Inc. is the largest digital pharmaceutical platform serving businesses outside of hospitals in China. The company focuses on promoting the healthy development of the industry through its efficient Internet pharmaceutical distribution network and innovative healthcare technology, aiming to make quality medical care and good medicine accessible to all.
YTD Price Performance: 0.89%
Average Trading Volume: 4,097,916
Technical Sentiment Consensus Rating: Buy
Find detailed analytics on 9885 stock on TipRanks’ Stock Analysis page.
